Kais Zakharia to Humans
This is a "connection" page, showing publications Kais Zakharia has written about Humans.
Connection Strength
0.057
-
Zakharia K, Klair JS, Murali AR. Unusual Etiology for Transaminitis. Dig Dis. 2019; 37(6):518-520.
Score: 0.023
-
Zakharia K, Tabibian A, Lindor KD, Tabibian JH. Complications, symptoms, quality of life and pregnancy in cholestatic liver disease. Liver Int. 2018 03; 38(3):399-411.
Score: 0.020
-
Toyohara T, Nakazawa T, Zakharia K, Shimizu S, Miyabe K, Harada K, Notohara K, Yamada T, Hayashi K, Naitoh I, Hayashi K, Kataoka H. IgG4-related Sclerosing Cholangitis Complicated with Cholangiocarcinoma and Detected by Forkhead Box P3 Immunohistochemical Staining. Intern Med. 2021 Mar 15; 60(6):859-866.
Score: 0.006
-
Zakharia Y, Zakharia K, Rixe O. Axitinib: from preclinical development to future clinical perspectives in renal cell carcinoma. Expert Opin Drug Discov. 2015; 10(8):925-35.
Score: 0.004
-
Nakamura I, Zakharia K, Banini BA, Mikhail DS, Kim TH, Yang JD, Moser CD, Shaleh HM, Thornburgh SR, Walters I, Roberts LR. Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling. PLoS One. 2014; 9(4):e92273.
Score: 0.004